Cargando…
Correction to: In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
Autores principales: | Sermet-Gaudelus, I., Renouil, M., Fajac, A., Bidou, L., Parbaille, B., Pierrot, S., Davy, N., Bismuth, E., Reinert, P., Lenoir, G., Lesure, J. F., Rousset, J. P., Edelman, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109304/ https://www.ncbi.nlm.nih.gov/pubmed/30143037 http://dx.doi.org/10.1186/s12916-018-1138-z |
Ejemplares similares
-
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot study
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2007) -
Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons
por: Pranke, Iwona, et al.
Publicado: (2018) -
Interest of colchicine for the treatment of cystic fibrosis patients. Preliminary report.
por: Sermet-Gaudelus, I, et al.
Publicado: (1999) -
Inflammation and CFTR: might neutrophils be the key in cystic fibrosis?
por: Witko-Sarsat, V, et al.
Publicado: (1999) -
The CF-CIRC study: a French collaborative study to assess the accuracy of Cystic Fibrosis diagnosis in neonatal screening
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2006)